Valproate containing medicines - Important Safety Information from Sanofi Aventis Ireland as approved by the HPRA (19.02.24)

Notice type: 3rd Party Publications

Date: 19/02/2024

Problem Or Issue:

Important Safety Information from Sanofi-Aventis Ireland Limited regarding Valproate - containing medicines: new measures regarding the potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the 3 months prior to conception


Important Safety Information Valproate - containing medicines

« Back